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Abstract
Pentachlorophenol (PCP) and dichlorodiphenyltrichloroethane (DDT) are pesticides that have 
been widely used and significantly contaminate the environment. Both are found in human blood 
and have been shown to alter the lytic and binding function of human natural killer (NK) cells. 
Interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) are pro-inflammatory cytokines 
which regulate immune responsiveness to pathogens and tumors. Their levels require very tight 
control to prevent loss of immune competence or excessive inflammation. Here we examined the 
capacity of PCP and DDT to alter the secretion of these critical pro-inflammatory cytokines from 
increasingly reconstituted (more complex) preparations of human immune cells which included 
NK cells, monocyte-depleted (MD) peripheral blood mononuclear cells (PBMCs) (a preparation 
that is predominantly lymphocytes), and PBMCs (a preparation containing lymphocytes and 
monocytes). Results indicated that exposure to PCP decreased IFNγ secretion at the highest 
exposures (2.5 and 5 μM) and increased IFNγ secretion at lower concentrations. These effects 
were seen irrespective of the complexity of the cell preparation. PCP at 2.5 and 5 μM generally 
decreased TNFα secretion from NK cells but had inconsistent effects in MD-PBMCs and PBMCs. 
Exposure of the each of the immune cell preparations to DDT caused increases in IFNγ secretion. 
DDT (2.5 μM) increased TNFα secretion from MD-PBMCs after either 24 h or 48 h of 
exposure. The mechanism of PCP-induced increases in IFNγ secretion appears to involve the p38 
mitogen activated protein kinase (MAPK) pathway, based on loss of PCP stimulated increases 
when this pathway was inhibited.
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Pentachlorophenol (PCP) and dichlorodiphenyltrichloroethane (DDT) are organochlorine 
compounds that contaminate the environment due to their various uses (ATSDR, 2001 
ATSDR, 2002; Cirelli, 1978; CDC 2003; 2005; Geisz et al., 2008; Turusov et al., 2002). 
PCP has been used as a fungicide, insecticide, herbicide, and as a wood preservative (Cirelli, 
1978) and is found in human blood at concentrations averaging 0.15 μM in individuals with 
no known exposure (Cline et al., 1989; Uhl et al., 1986). It is found in much higher levels 
(0.26 −5 μM) in the serum of those who have lived in log homes where the wood was treated 
with PCP (Cline et al., 1989). Exposure to PCP has been associated with lymphoma, 
myeloma and kidney cancer (Demers et al., 2006; Cooper & Jones, 2008). DDT has been 
widely used as an insecticide and agricultural pesticide (CDC 2003; 2005; Geisz et al., 2008; 
Turusov et al., 2002). It is no longer used in the USA. However, it is still used to control 
mosquitos and other pests in many other countries (CDC 2003; 2005) and is found in 
measurable concentrations in blood samples within the US population (Thornton et al., 
2002; Patterson et al., 2009). In those countries where DDT is still used, such as Mexico, it 
has been found in human serum at concentrations as high as 23,169 ng/g of lipid 
(approximately 260 nM) (Koepke et al., 2004; Trejo-Acevedo et al., 2009). DDT levels in 
blood have been associated with decreased numbers of natural killer (NK) cells as well as 
decreased NK function (Svensson et al., 1994; Eskenazi et al., 2009). Additionally, exposure 
to DDT has been linked to increased incidences of liver, pancreatic, breast, and testicular 
cancers as well as leukemia (Eskanazi et al., 2009; Cohn et al., 2007)
The pro-inflammatory cytokines interferon gamma (IFNγ) and tumor necrosis factor alpha 
(TNFα) regulate the functions of both innate and adaptive immune cells. IFNγ increases 
antigen presentation on macrophages by increasing their expression of MHC class I 
molecules and regulates T cell immune response through Th1 cells. It is also involved in the 
recruitment of innate immune cells to sites of infection or tumor (Zaidi & Merlino, 2011). 
IFNγ is secreted by T cells, NK cells, and to a lesser extent by myeloid lineage cells such as 
macrophages (Billiau & Matthys, 2009; Darwich et al., 2008). It is an approximately 17kD 
protein and is dimerized in its physiologically active form (Billau & Matthys, 2009). TNFα 
is initially produced as a 26 kD transmembrane protein that is then released from the 
membrane as a 17kD protein by a wide array of cells including T cells, natural killer (NK) 
cells, and monocytes (Goetz et al., 2004). In addition to activating the inflammatory immune 
response, it is also able to causes apoptosis as well as cell proliferation (Guicciardi & Gores, 
2009; Silke, 2011). Both IFNγ and TNFα are a potent inflammatory stimuli and as such 
have the capacity to cause chronic inflammation. Chronic inflammation has been shown to 
be associated with a number of disease states including, rheumatoid arthritis, Crohn’s 
disease and several cancers (Macarthur et al., 2004; Tracey et al., 2008; Grivennikov & 
Karin, 2011). Thus, it important that IFNγ and TNFα levels in the body are carefully 
regulated to prevent either a loss of immune competency or the risks that occur due to 
chronic inflammation.
Previous studies have shown that the ability of human NK cells to destroy tumor target cells 
is inhibited by both PCP and DDT. Additionally, both of these compounds decreased the 
ability of NK cells to bind to tumor target cells (Reed et al., 2004; Nnodu & Whalen, 2008; 
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Udoji et al., 2010; Hurd et al., 2012; Hurd-Brown et al., 2013) while decreasing the 
expression of certain cell-surface proteins needed for the binding process (Hurd et al., 2012; 
Hurd-Brown et al., 2013). Based on the results from previous studies on the effects of PCP 
and DDT on immune function we hypothesize that PCP and DDT may alter the secretion of 
IFNγ and/or TNFα from human immune cells.
The current study examined the effects of exposures to PCP or DDT exposures on secretion 
of IFNγ and TNFα from NK cells, monocyte-depleted (MD) peripheral blood mononuclear 
cells (PBMCs), and PBMCs. Examination of the effects of these compound on secretion of 
these cytokines from preparations of immune cells that contained different cell types 
allowed us to determine whether the effects of the compounds vary as the system becomes 
more reconstituted (NK lymphocytes versus T and NK lymphocytes (MD-PBMCs) 
versus T and NK lymphocytes + monocytes (PBMCs)) and thus more closely resembles 
the physiological setting. An additional goal of this study was to investigate the mechanism 
of any increases in cytokines induced by exposure to the compounds, using specific 
signaling pathway inhibitors.
MATERIALS AND METHODS
Preparation of NK cells
NK cells were prepared from buffy coats (source leukocytes from healthy adult donors) 
purchased from Key Biologics, LLC (Memphis, TN) or leukocyte filters (PALL-RCPL or 
FLEX) obtained from the Red Cross Blood Bank (Nashville, TN) using a rosetting 
procedure. RosetteSep human NK cell enrichment antibody cocktail (0.6–0.8 mL) (StemCell 
Technologies, Vancouver, British Columbia, Canada) was added to 45 mL of buffy coat (as 
decribed by the manufacturer) (Aoukaty & Tan, 2005; Almughamsi & Whalen, 2016). The 
mixture was incubated for 20 min at room temperature (~ 25° C). Approximately 8 mL of 
the mixture was layered onto 4 mL of LymphoSep™ cell separation medium (1.077 g/mL) 
(MP Biomedicals, Irvine, CA) and centrifuged at 1200 g for 30–50 min. NK cells were 
collected and washed twice with phosphate buffered saline (PBS) pH 7.4 and stored in 
complete media (RPMI-1640 supplemented with 10% heat-inactivated bovine calf serum 
(BCS), 2 mM L-glutamine and 50 U penicillin G with 50 μg streptomycin/ml) at 1 million 
cells/mL at 37 °C and air/CO2, 19:1.
Preparation of monocyte- depleted PBMCs and PBMCs
PBMCs were isolated from Leukocyte filters (PALL- RC2D) obtained from the Red Cross 
Blood Bank Facility (Nashville, TN) as described in Meyer et al., 2005. Filters are used by 
the Red Cross to remove white blood cells from units of blood. Each filter represents a 
separate blood donor and is numbered. Leukocytes were retrieved from the filters by 
back-flushing them with elution medium (PBS containing 5 mM disodium EDTA and 2.5% 
[w/v] sucrose) and collecting the eluent. Eluent contained the leukocytes with red cell 
contamination. Eluent was layered onto LymphoSep™ (1.077g/mL) and centrifuged as 
described above. Granulocytes and red cells pelleted at the bottom of the tube while the 
PBMCs floated on the LymphoSep™. PBMCs were collected and washed (250 g, 10 min.) 
with PBS. Cells were then suspended in complete medium which consisted of RPMI-1640 
Massawe et al. Page 3













supplemented with 10% heat-inactivated BCS, 2 mM L-glutamine and 50 U penicillin G 
with 50 μg streptomycin/mL. This preparation constituted PBMCs. Monocyte-depleted 
PBMCs (10–20% CD16+, 10–20 % CD56+, 70–80% CD3+, 3–5% CD19+, 2–20% 
CD14+) were prepared by incubating PBMCs in glass Petri dishes (150 × 15 mm) at 
37 °C and air/CO2, 19:1 for 45 min. The cell suspension was then removed and placed 
onto clean glass Petri dishes for another 45 min at 37 °C and air/CO2, 19:1. The non-
adherent cells were then collected from the petri dishes. The resulting preparation was 
predominantly NK and T lymphocytes as the monocytes and B lymphocytes adhered to 
the glass (Koller et al., 1973).
Chemical Preparation
DDT and PCP were purchased from Sigma-Aldrich (St. Louis, MO). Stock solutions were 
prepared as 100 mM solutions in Dimethylsulfoxide (DMSO). Desired concentrations of 
either DDT or PCP were prepared by dilution of the desired stock into cell culture media. 
Appropriate DMSO dilutions were used as controls. DMSO was never greater than 
0.02% in any of the incubations.
Inhibitor Preparation
Enzyme inhibitors were purchased from Fischer Scientific (Pittsburgh, PA). The stock 
solution for each inhibitor was a 50 mM solution in dimethylsulfoxide (DMSO). MEK 1/2 
pathway inhibitor (PD98059), p38 inhibitor (SB202190), JNK inhibitor(B178D3), and 
NFκB inhibitor (BAY11-7085) were prepared by dilution of the stock solution into cell 
culture media mixture.
Cell Treatments
PBMCs, MD-PBMCs, and NK cells (at a concentration of 1.5 million cells/ mL) were 
treated with PCP (0.05–5 μM) or DDT (0.025–2.5 μM) and appropriate control for 24 h, 48 
h, and 6 days. Once the incubation period was complete, the cells were pelleted and 
supernatants were obtained and stored at −70 C until assaying for IFNγ or TNFα. For the 
pathway inhibitor experiments, PBMCs were treated with enzyme inhibitors 1 h prior to 
adding PCP at concentrations of 0.25, 0.1, and 0.05 μM PCP for 24 h. After the cells were 
incubated, the cells were pelleted and supernatants were obtained and stored at −70 C until 
assaying for IL-1β.
Cell Viability
Cell viability was measured at the end of the 24 h, 48 h and 6 day exposure period. Viability 
was determined using the trypan blue exclusion method. Cells were mixed with trypan blue 
and counted using a hemocytometer. The total number of cells and the number of dead were 
counted for both control and treated cells to determine the percent viable cells.
IFNγ and TNFα secretion assays
IFNγ or TNFα levels were assessed using OptEIA™ enzyme-linked immunosorbent assay 
(ELISA) human IFNγ or TNFα kit (BD-Pharmingen, San Diego, CA). A 96 well microwell 
plate specific to ELISA was incubated with Capture antibody overnight. The capture 
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antibody was removed by washing with PBS containing 0.05% Tween-20. Non-specific 
binding was blocked with by incubation with blocking buffer for 1 h. This incubation was 
followed by removal of the blocking solution and incubation of the plate with cell 
supernatants and IFNγ or TNFα standards for 2 h. Following the incubation with samples 
and standards they were removed and detection antibody was added and incubated for 1 h. 
Removal of detection antibody was followed by application of the substrate solution for a 30 
min incubation. Incubation with substrate was ended by addition of acid and the absorbance 
was measured at 450 nm on a Thermo Labsystems Multiskan MCC/340 plate reader (Fisher 
Scientific).
Statistical analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student’s t test. Data 
were initially compared within a given experimental setup by ANOVA. A significant 
ANOVA was followed by pair wise analysis of control versus exposed data using Student’s t 
test, a p value of less than 0.05 was considered significant.
RESULTS
Viability of NK cells, MD-PBMCs, and PBMCs exposed to PCP and DDT
When immune cells were exposed to concentrations of PCP from 0.05 to 5 μM, there was no 
effect on the viability of the cells compared to control cells. Data not shown. The viability of 
NK cells, MD-PBMCs, and PBMCs was also unaffected by exposure to DDT. Data not 
shown.
Viability of monocyte-depleted PBMCs treated with selective enzyme inhibitors and then 
exposed to PCP
The effects of exposures to selective enzyme inhibitors in the presence and absence of 
0.05,0,1, 0.25 μM PCP on the viability of MD-PBMCs was also examined. The presence of 
inhibitors did not negatively affect the viability of the MD-PBMCs compared to control 
cells.
Secretion of IFNγ and TNFα from NK cells exposed to PCP
Effects of PCP exposures on IFNγ secretion are shown in Table 1A. IFNγ secretion was 
increased by exposure to 1 or more concentrations of PCP after 24 h. The concentrations that 
produced increased secretion varied from donor to donor. However, 0.1 μM PCP caused a 
significant increase in IFNγ secretion in all donors tested. The magnitude of the increase in 
secretion following a 24 h exposure to PCP also varied among donors. The range for 
maximum fold increase in IFNγ secretion stimulated by PCP was 1.5 fold (F345) to 8.8 fold 
(F338). PCP-induced increases in IFNγ secretion (at 1 or more concentration) were also 
seen at the 48 h and 6 day exposures. In addition to the PCP-stimulated increases, there were 
also PCP-stimulated decreases in IFNγ after 24 h exposures to 2.5 and 5 μM PCP in cells 
from each of the donors (Table 1A). This pattern maintained at 48 h and 6 days. Figure 1A 
shows data from a representative experiment (F365). There were significant decreases in 
TNFα secretion from 3 of 4 donors at 24 hrs. However the extent of the decrease varied 
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from donor to donor (Table 1B). This same pattern of effect on TNFα secretion was seen 
after 48 h and 6 days of exposure to PCP.
Secretion of IFNγ and TNFα from MD-PBMCs exposed to PCP
As with the NK cells, MD-PBMCs (a preparation is largely NK cells and T cells) were 
exposed to PCP (0.05–5 μM) for 24 h, 48 h, and 6 d after which IFNγ secretion was 
measured (Table 2A). Of the 5 donors that were studied, cells from 4 donors showed 
statistically significant increases in IFNγ secretion with at least 1 concentration of PCP after 
a 24 h exposure. Cells from all donors showed an increase in secretion after 48 h exposures 
to PCP at one or more concentration. The maximum fold increase seen after 48 h ranged 
from 1.3 fold (F209) to 20.5 fold (F314). Similar results were seen after 6 d of exposure to 
PCP. Results from a representative experiment (F312) are inFigure 1B. The effects of 
exposing MD-PBMCs to PCP on TNFα secretion are shown in Table 2B. There was no 
consistent effect of any given concentration of PCP on secretion of TNFα from cells from 
any of the donors at any length of incubation.
Secretion of IFNγ and TNFα from PBMCs exposed to PCP
PBMCs (a cell preparation containing lymphocytes and monocytes) were exposed to PCP as 
described above (Table 3A). PBMCs from all donors showed a statistically significant 
increase in IFNγ when exposed to one or more concentration of PCP. The concentrations at 
which significant increases were seen varied among the donors tested as did the length of 
incubation at which the increase occurred. Cells from 3 of 4 donors showed increases in 
IFNγ secretion at the 24 h exposure. These increase ranged from 2.3 (F197) to 5.1 (F214). 
The fourth donor (F238) showed a significant increase in IFNγ secretion after 6 days of 
exposure. All donors showed significant decreases in IFNγ secretion at either the 5 or 2.5 
μM concentrations of PCP at each length of exposure. Figure 1 C shows the data from F211. 
PBMCs did not show any consistent alterations of TNFα secretion when exposed to PCP 
(Table 3B).
Secretion of IFNγ and TNFα from NK cells exposed to DDT
NK cells were exposed to 0.025 to2.5 μM DDT and appropriate control for 24 h, 48 h, and 6 
d and IFNγ secretion was measured (Table 4A). As was seen with PCP exposures, there 
were statistically significant increases in IFNγ secretion with exposure to at least one 
concentration of DDT at one or more length of exposure. Cells from 3 of 4 donors showed 
statistically significant increases after 24 h of exposure while cells from donor F361 showed 
an increase in IFNγ secretion by the 48 h time point. Concentrations that caused increases 
varied from one donor to the next as did the magnitude of the increase. The maximum fold 
increases after 24 h exposures to DDT ranged from 1.5 fold (F375) to 3.6 fold (F366). 
Figure 2A shows representative results from F366. Similar effects were seen in most 
donors after 48 h. DDT-induced increases tended to diminish in cells exposed for 6 days 
possibly due to the length of time in culture. Exposure of pure NK cells to 0.025–2.5 μM 
DDT had little effect on the secretion of TNFα as compared to the control. This was the case 
in cells from all donors at all lengths of exposure (Table 4B).
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Secretion of IFNγ and TNFα from MD-PBMCs exposed to DDT
There were significant increases in IFNγ secretion from MD-PBMCs of all donors within 48 
h of exposure to DDT (Table 5A). The specific concentration that caused a significant 
increase differed among donors as did the maximum fold increase. For instance, cells from 
F308 showed a 1.4 fold increase in IFNγ secretion at the 1 μM exposure after 48 h, while 
cells from F304 exhibited an 8.8 fold increase at the 0.05 μM concentration of DDT after the 
same length of exposure. Representative results from F308 are shown in Figure 2B. As was 
seen with NK cells, increases in IFNγ seen with DDT exposures tended to decrease or 
disappear after 6 days of exposure. Increases in TNFα secretion were seen at the higher 
concentrations of DDT in cells from all donors at one or more length of exposure (Table 
5B). The increases were 1.64, 1.33, and 1.42 fold as compared to the control in F106, F178, 
and F180 at 24 h and 1.78 fold for F174 at 48 h. Results from a representative experiment 
(F106) are shown in Figure 2C.
Secretion of IFNγ and TNFα from PBMCs exposed to DDT
PBMCs from all donors showed significant increases in IFNγ secretion at a minimum of one 
concentration of DDT over the course of the 6 day exposures (Table 6A). Figure 2D shows 
the results from a representative experiment (F201). Exposure of PBMCs to DDT for 24 h, 
48 h, and 6 d had variable effects on secretion of TNFα (Table 6B).
PCP-induced Secretion of IFNγ from MD-PBMCs pre-treated with Selective Enzyme 
Inhibitors
NFκB Inhibitor (BAY 11-7085)—The effect of NFκB inhibition on PCP-induced 
increases in IFNγ were examined at 0.05, 0.1, and 0.25 μM PCP after a 24 h incubation. 
These concentrations were chosen based on the fact that, in the studies presented above, they 
were able to induce an increase in IFNγ secretion from the MD-PBMCs of 4 of the 5 
donors. NFκB was inhibited by pre-treating the MD-PBMCs with BAY 11-7085 (0.325 μM) 
for 1 h prior to a 24 h exposure to PCP. Inhibition of NFκB did not prevent PCP from 
stimulating an increase in IFNγ secretion from MD-PBMCs (Table 7). For example, there is 
a 2 fold increase in IFNγ secretion when MD-PBMCs from donor F374 are exposed to 0.25 
μM PCP in the absence of NFκB inhibitor. When the inhibitor is present this same PCP 
exposure causes a 3 fold increase in IFNγ secretion (Figure 3A). These results indicate that 
NFκB is not utilized by PCP to stimulate IFNγ secretion.
Mitogen activated protein kinase (MAP2K), MEK, Inhibitor (PD98059)—PCP-
stimulated secretion of IFNγ from MD-PBMCs where MEK had been inhibited with 
PD98059 (50 μM) was also examined (Table 7). Cells from 6 of the 8 donors exposed to 
PCP showed a lower fold increase in IFNγ secretion in the presence of the inhibitor. There 
was a 1.6 fold increase in IFNγ secretion from cells from donor F326 when MEK was active 
and no increase when MEK was inhibited (Figure 3B). These results suggest that the p44/42 
pathway may be being utilized by PCP to stimulate IFNγ secretion from MD-PBMCs from 
most donors.
p38 Inhibitor (SB202190)—Table 7 shows the effects of exposures to PCP on secretion 
of IFNγ from MD-PBMCs in the presence and absence of the p38 inhibitor SB202190. 
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Inhibition of p38 decreased the PCP-induced increases in IFNγ secretion in cells from each 
of the 4 donors tested. MD-PBMCs from donor F331 demonstrated a 1.7 fold increase when 
exposed to 0.1 μM PCP in the absence of p38 inhibitor and no increase when p38 was 
inhibited (Figure 3C). These data suggest that PCP is utilizing the p38 pathway to stimulate 
increases in IFNγ secretion.
JNK Inhibitor (BI78D3)—PCP-stimulated secretion of IFNγ was also examined in MD-
PBMCs where JNK had been inhibited with BI78D3 (Table 7). Cells from donors F326, 
F331, F370, F374, and F385 showed little to no effect of inhibiting JNK on the ability of 
PCP to stimulate IFNγ secretion. The fold increase in IFNγ secretion in response to 0.25 
μM PCP from F370 was 1.6 fold when JNK was not inhibited and 3 fold when JNK was 
inhibited. Cells from donors F326 showed increased ability of 0.25 μM PCP to stimulate 
IFNγ secretion when JNK was inhibited (1.4 fold in the absence of inhibitor versus 2.4 fold 
in the presence of inhibitor) (Figure 3D). These results suggest that the JNK pathway is not 
utilized to any great extent by PCP to stimulate increases in IFNγ secretion.
DISCUSSION
Due to their uses in insect control, wood preservation and other applications (CDC, 2003; 
2005; Cirelli, 1978; U.S. EPA, 2001), DDT and PCP are found in human blood samples 
(Thornton et al., 2002; Patterson et al., 2009; Cline et al., 1989; Uhl et al., 1986; CDC, 
2005). Serum DDT levels as high as 23,169 ng/g of lipid (approximately 260 nM) have been 
found (Koepke et al., 2004; Trejo-Acevedo et al., 2009). Decreases in NK cell numbers and 
function have been associated with blood levels of DDT (Eskenazi et al., 2009; Svensson et 
al., 1994). PCP has been detected at an average level of 0.15 μM for individuals with no 
known exposure and levels of 0.26 −5 μM in the serum of individuals residing in PCP-
treated log homes (Cline et al., 1989; Uhl et al., 1986). Both DDT and PCP are associated 
with increases in the incidences of certain cancers (Demers et al., 2006; Cohn et al., 2007). 
Past studies have shown that both PCP and DDT inhibit the lytic function of human NK 
cells and decrease their expression of key cell surface proteins (Udoji et al., 2010; Reed et 
al., 2004; Taylor et al., 2005; Nnodu & Whalen, 2008; Hurd et al., 2013).
IFNγ is an important pro-inflammatory cytokine (Billiau & Matthys, 2009; Darwich et al., 
2008; Kraaij et al., 2014). It has role in both decreasing the growth of tumors and in some 
cases enhancing their growth (Zaidi & Merlino, 2011) as well as in controlling infections 
(Schroder et al., 2004). TNFα elevation is associated with a number of cancers including 
bladder, breast and prostate (Balkwill & Mantovani, 2001) and can stimulate factors that 
increase invasiveness and metastasis of cancer cells (Kamata et al., 2005). Elevated levels of 
TNFα also appear to be part of the pathology of Crohn’s disease, psoriasis, and rheumatoid 
arthritis (Tracey et al., 2008). Thus, dysregulation of IFNγ and TNFα secretion (either too 
much or too little) could lead to accelerated tumor growth, diseases such as rheumatoid 
arthritis, or infection (Zaidi & Merlino, 2011; Tracey et al., 2008; Balkwill & Mantovani, 
2001). Previous studies have shown that butyltin and brominated flame retardant 
environmental contaminants are able to disrupt the secretion of IFNγ from immune cells 
(Lawrence et al., 2015; Almughamsi & Whalen, 2016) and that butyltins are able to alter 
secretion of TNFα (Hurt et al., 2012). Thus, the current study examined whether DDT 
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and/or PCP exposures in ex vivo immune cell preparations lead to alterations of IFNγ 
and /or TNFα secretion. Three immune cell preparations of varying complexity were used in 
examining the effects of PCP and DDT on secretion of these cytokines, in order to discern 
whether the composition of the cell preparation influences any effects seen with the 
compounds.
The results of this study showed that PCP caused both increases and decreases in IFNγ 
secretion depending on the concentration of PCP to which the cells were exposed. Decreases 
in IFNγ secretion were seen at either the 2.5 or 5 μM PCP exposures in each of the different 
cell preparations (NK, ND-PBMCs, PBMCs) after 24 h. The concentration range where 
increases occurred was at the lower levels of exposure (0.5–0.05 μM). The effects seen after 
a 24 h exposure to PCP tended to maintain after 48 h and 6 day exposures to PCP in each of 
the different cell preparations. After 24 h the average maximum fold increase in IFNγ 
secretion for NK cells was 4.3 fold (range: 1.5–8.8 fold) with all donors showing some 
increase. The average maximum fold increase in IFNγ secretion seen in MD-PBMCs after a 
24 h exposure was 2.4 fold (range: 1.5–4.8 fold) and was seen in 4 of 5 donors and that of 
the PBMCs was 3.7 fold (range 2.3–5 fold) and was seen in 3 of 4 donors. Thus, there was a 
relatively broad range of increases in each of the cell preparations that was donor dependent 
after 24 h of exposure.
Previous studies have shown that exposure to PCP for 24 h lead to decreases in the ability of 
NK lymphocytes to destroy tumor cells (lytic function) (Reed et al., 2004, Nnodu & Whalen, 
2008). Decreases in lytic function were seen at higher PCP concentrations while 
concentrations below 0.5 μM had no effect on this function. The current study shows that 
IFNγ secretion is also decreased at the highest PCP exposures in NK lymphocytes. Those 
concentrations that caused little to no effect on lytic function however, are able to increase 
the ability of the NK cell to secrete IFNγ. Thus, while exposures to high concentrations of 
PCP seem to be generally inhibitory to NK cell function, exposures to lower levels stimulate 
the ability of the NK cell to produce the important immune response activator, IFNγ. As 
mentioned above, exposure to PCP is associated with increases in the incidences of certain 
cancers (Demers et al., 2006). However, the concentration of PCP in individuals who 
developed these cancers was not determined.
The effects of PCP exposure on IFNγ secretion were similar among all the cell types 
examined (NK cells, MD-PBMCs, and PBMCs). There tended to be a biphasic effect of 
PCP on IFNγ secretion in each of the cell preparations. As was noted above, higher 
concentrations of PCP (5 and 2.5 μM) tended to decrease IFNγ secretion and lower 
concentrations (0.1 and 0.05 μM) tended to increase its secretion. A possible 
explanation for this biphasic effect is that at the higher concentration PCP would 
interact with a very wide spectrum of cellular components and this would result in 
multiple simultaneous (and possibly competing) effects, with the resulting overall 
impact on the cell being inhibitory of its function. As the concentration of PCP 
decreases (such as at 0.1 or 0.05 μM), it will interact with far fewer components and the 
result of those interaction will be to stimulate the secretion of IFNγ.
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No consistent effects on TNFα secretion were seen when these immune cell preparations 
were exposed to PCP. This was in contrast to the consistent decreases and increases seen in 
IFNγ secretion. Thus, the effects of PCP on secretion of these 2 cytokines are markedly 
different. This may reflect the fact that regulation of their secretion and production while 
having overlap is distinct for each of these cytokines (Tsukaguchi et al., 1999).
Exposure of the various cell preparations to DDT caused increases in IFNγ secretion at one 
or more concentration after 48 h of exposure. This effect was seen in each of the different 
types of cell preparation (NK, MD-PBMCs, PBMCs). The concentrations of DDT where 
increases in IFNγ secretion were seen ranged from the highest concentration tested (2.5 μM) 
to the lowest concentration (0.025 μM), this is in contrast to PCP where only the lower 
concentrations (0.5–0.05 μM) caused increased secretion. Additionally, the most consistent 
and greatest fold increases seen with DDT occurred after 48 h of exposure while occurring 
after 24 h with PCP treatments. DDT caused no consistent decreases in IFNγ in any of the 
cell preparations while PCP consistently caused decreases at the 2.5 and/or 5 μM exposures. 
DDT exposures increased TNFα secretion from MD-PBMCs after 24 or 48 h. However, 
there were no consistent effects of DDT exposures in either NK cells or PBMCs.
Previous studies have shown that other compounds that contaminate the environment, 
brominated flame retardants and butyltins, are able to alter the secretion of IFNγ from 
immune cells (Almughamsi & Whalen, 2016; Lawrence et al. 2015). The flame retardant, 
HBCD, and the butyltins, tributyltin (TBT) and dibutyltin (DBT), all tended to increase 
IFNγ secretion at the lower exposure concentrations, as did PCP. Another pro-inflammatory 
cytokine, IL-1β has also been shown to be increased by exposures to HBCD and TBT 
(Anisuzzaman & Whalen, 2016; Brown & Whalen, 2015).
As mentioned above, PCP tended to cause consistent increases in IFNγ secretion from MD-
PBMCs at concentration between 0.25 and 0.05 μM. Thus, we examined the role of various 
signaling pathways in regulating the PCP-induced increases in IFNγ secretion. IFNγ levels 
in immune cells can be regulated by a variety of signaling pathways including NFκB and the 
MAPKs, p38, p44/42(also known as ERK1/2) and JNK (Schoenborn & Wilson, 2007; Girart 
et al., 2007; Samten et al., 2008). The results indicated that both the p44/42 and the p38 
MAPK pathways may be stimulated by PCP exposures leading to increased IFNγ secretion. 
Previous studies indicated that HBCD-induced increases in IFNγ secretion were dependent 
on the p44/42 pathway as well (Almughamsi & Whalen, 2016). Additionally, increases in 
IL-1β stimulated by HBCD and TBT were also dependent on the p44/42 pathway.
PCP and DDT showed variations in their effects on IFNγ secretion (specific lengths and 
concentrations of exposure) that was donor dependent. Indicating that there may be 
significant differences in the consequences of exposures to these (and other chemical 
contaminants) from one individual to the next. This would be important in assessing the risk 
from exposures for a variety of potential health consequences. The concept of personalized 
treatment of a number of diseases, most especially cancer (Madureira & de Mello, 2014) has 
begun to evolve. The results from this study indicate that there may individualized responses 
to these environmental toxicants.
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Due to the importance of IFNγ in regulating immune responses to pathogens and its 
potential to cause unwanted inflammation, the alterations of its secretion from immune cells, 
as have been seen with PCP and DDT exposures, have significant implications. For instance 
if levels are decreased, as was seen with 2.5 and 5 μM PCP, then an inadequate stimulation 
of other components of the immune response would occur. Conversely, if levels are 
increased by PCP or DDT (as seen in this study), the potential for unwarranted inflammation 
occurs. Such excessive inflammation is capable of fueling pathological responses such as 
atherosclerosis as well as tumor growth and development (Tracey et al., 2008; Macarthur et 
al., 2004). Inflammation occurring in the absence of a microorganism has been referred to as 
“sterile inflammation” (Chen & Nunez, 2010). Thus, compounds such as PCP or DDT could 
result in sterile inflammation in exposed individuals due to their ability to induce the 
production of pro-inflammatory cytokines such as IFNγ.
A previous study showed that butlytins (both TBT and DBT) altered secretion of TNFα 
from human white blood cells. That study showed that TBT caused decreased secretion of 
TNFα in NK cells. However TBT (at lower concentrations) stimulated secretion of TNFα in 
cell preparations that contained both T and NK cells (monocyte-depleted PBMCs). DBT at 
higher concentrations also decreased TNFα secretion and increased secretion at lower 
concentrations in both NK cell and the MD-PBMCs (Hurt et al., 2013). This is in contrast to 
the effects of PCP and DDT on secretion of TNFα where there was no consistent 
modification of secretion except with PCP exposures in the MD-PBMCs.
In summary, the current study shows that secretion of IFNγ in three distinct immune cell 
preparations is altered by PCP and DDT exposures. Exposures to PCP result in significant 
decreases in IFNγ secretion at the highest exposure levels (2.5 and 5 μM) and in increases in 
IFNγ secretion at lower concentrations. The PCP-induced increases in IFNγ appear to 
utilize both the p44/42 (ERK1/2) and p38 MAPK pathways. Additionally, DDT stimulates 
secretion of IFNγ from each of the three cell preparations.
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Effects of 24 h, 48 h and 6 day exposures to PCP on IFNγ secretion from NK cells, MD-
PBMCs, and PBMCs. A) NK cells exposed to 0.05–5μM PCP (cells from donor F365); B) 
MD-PBMCs exposed to 0.05–5μM PCP (cells from donor F312); C) PBMCs exposed to 
0.05–5μM PCP (cells from donor F211). Values are mean±S.D. of triplicate determinations. 
* indicates a significant difference from the control (p<0.05)
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Effects of 24 h, 48 h and 6 day exposures to DDT on IFNγ secretion from NK cells, MD-
PBMCs, and PBMCs and TNFα secretion from MD-PBMCs. A) NK cells exposed to 
0.025–2.5μM DDT (IFNγ secretion from cells of donor F366); B) MD-PBMCs exposed to 
0.025–2.5μM DDT (IFNγ secretion from cells of donor F308); C) MD-PBMCs exposed to 
0.025–2.5μM DDT (TNFα secretion from cells of donor F106); D) PBMCs exposed to 
0.025–2.5μM DDT (IFNγ secretion from cells of donor F201). Values are mean±S.D. of 
triplicate determinations. * indicates a significant difference from the control (p<0.05)
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Effects of 24 h exposure to 0.05, 0.1, and 0.25 μM PCP on IFNγ secretion from MD-
PBMCs pre-treated with selective enzyme inhibitors. A) NFκB Inhibitor (BAY 11-7085) 
(cells from donor F374); B) MEK Inhibitor (PD98059) (cells from donor F326); C) p38 
Inhibitor (SB202190) (cells from donor F331; D) JNK inhibitor (B178D3) (cells from donor 
F326). Values are mean±S.D. of triplicate determinations. * indicates a significant increase 
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compared to no PCP (0), p<0.05 **indicates a significant increase compared to no PCP + 
inhibitor, p<0.05.
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Table 1A
Effects of 24 h, 48 h, 6 day exposures to PCP on IFNγ secretion from NK cells.
24 h Interferon gamma secreted in pg/mL (mean±S.D.)
[PCP] μM F335 F338 F345 F365
0 1515±1 21±2 3400±50 532±39
0.05 29±1* 135±3* 2505±145ǂ 766±21*
0.1 31±0* 126±26* 5031±44* 984±20*
0.25 7±0ǂ 184±3* 3462±110 852±40*
0.5 69±1* 61±4* 1672±10ǂ 1163±50*
1 25±0* 32±1* 675±20ǂ 654±75
2.5 7±0ǂ 0±1ǂ 155±30ǂ 110±2ǂ
5 4±0ǂ 0±2ǂ 0±11ǂ 11±2ǂ
48 h Interferon gamma secreted in pg/mL (mean±S.D.)
[PCP] μM F335 F338 F345 F365
0 9±1 231±3 4623±352 1297±68
0.05 33±2* 94±2ǂ 5312±460 1331±21
0.1 123±2* 72±1ǂ 4969±72 1363±25
0.25 16±0.3* 111±2ǂ 3367±116ǂ 1636±123*
0.5 15±1* 739±5* 2331±19ǂ 2010±224*
1 10±0.2 177±12ǂ 873±89ǂ 2028±204*
2.5 3±1ǂ 53±3ǂ 200±56ǂ 841±150ǂ
5 0±0.7ǂ 8±1ǂ 0±15ǂ 47±17ǂ
6 day Interferon gamma secreted in pg/mL (mean±S.D.)
[PCP] μM F335 F338 F345 F365
0 87±0.7 228±5 5063±69 1563±64
0.05 48±2ǂ 142±39 2992±122ǂ 1702±21
0.1 100±1* 113±2ǂ 2806±26ǂ 2391±97*
0.25 105±1* 284±7* 4762±78ǂ 1469±130
0.5 17±2ǂ 100±5ǂ 1992±0ǂ 1842±22*
1 21±1ǂ 126±2ǂ 716±25ǂ 1658±60
2.5 8±0.4ǂ 14±2ǂ 503±69ǂ 1003±89ǂ
5 4±0.2ǂ 11±0.4ǂ 0±17ǂ 61±14ǂ
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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Table 1B
Effects of 24 h, 48 h, 6 day exposures to PCP on TNFα secretion from NK cells.
24 h TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM KB138 KB184 KB190 KB128
0 170±12 742±11 72 ± 26 54±2
0.1 283±151 538±112 601±139* ND
0.25 97±17ǂ 681±31 562±32* 51±7
0.5 106±9ǂ 687±17ǂ 344±101* 35±1ǂ
1 215±88 816±46 390±183 38±3ǂ
2.5 0±23ǂ 456±21ǂ 176±80 12±1ǂ
5 0±0ǂ 295±31ǂ 238±74* 0±1ǂ
48 h TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM KB138 KB184 KB190 KB128
0 56±14 66±178 0±2 407±20
0.1 68±15 0±19 0±2 ND
0.25 49±8 0±7 2±11 378±98
0.5 54±8 0±23 0±2 395±86
1 43±7 182±150 0±4 392±25
2.5 8±2ǂ 0±47 0±1 162±26ǂ
5 0±1ǂ 0±39 0±1 29±1ǂ
6day TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM KB138 KB184 KB190 KB128
0 21±4 0±12 0±25 244±36
0.05 21±2 0±7 0±16 ND
0.1 26±1 0±12 0±5 150±26ǂ
0.25 20±1 0±5 0±2 156±10ǂ
0.5 12±2ǂ 0±22 0±3 185±8
1 12±1ǂ 0±24 0±10 193±33
2.5 4±1ǂ 0±3 0±4 52±3ǂ
5 2±2ǂ 0±5 0±32 5±0ǂ
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined




































































































































































































































































































































































































































































































































































































































































































































































































Massawe et al. Page 26
Table 2B
Effects of 24 h, 48 h, 6 day exposures to PCP on TNFα secretion from MD-PBMCs.
24 h TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM F100 F101 F106 F170
0 389±23 777±27 1767±133 381±16
0.1 ND 432±357 1418±175 455±108
0.25 450±98 650±10ǂ 1550±78 252±32
0.5 373±8 572±40ǂ 1235±35ǂ 397±78
1 471±123 648±12ǂ 1863±232 399±36
2.5 492±62 671±82 1490±113 143±27ǂ
5 450±32 829±13 1470±182 476±204
10 405±95 776±24 857±30ǂ 587±41
48 h TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM F100 F101 F106 F170
0 192±19 239±4 834±42 3±40
0.1 ND 296±135 797±44 64±8
0.25 249±46 459±105 942±446 89±17
0.5 227±42 301±95 1010±10* 90±20
1 305±18* 340±24* 10950±8357 98±15.0
2.5 330±34* 257±4* 824±16 117±9*
5 269±13* 317±3* 957±74 187±11*
10 203±41 372±4* 717±234 219±5*
6day TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM F100 F101 F106 F170
0 524±22 100±11 1072±72 301±15
0.05 ND 54±16ǂ 573±82ǂ 215±42
0.1 358±32ǂ 47±6ǂ 129±19ǂ 239±37
0.25 287±45ǂ 25±12ǂ 653±34ǂ 230±28ǂ
0.5 183±69ǂ 25±27ǂ 888±38ǂ 249±47
1 169±61ǂ 0±3ǂ 656±30ǂ 254±40
2.5 169±61ǂ 0±5ǂ 670±10ǂ 250±14ǂ
5 132±34ǂ 0±6ǂ 470±10ǂ 250±25
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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Table 3A
Effects of 24 h, 48 h, 6 day exposures to PCP on IFNγ secretion from PBMCs
24 h Interferon gamma secreted in pg/mL (mean±S.D.)
[PCP] μM F197 F211 F214 F238
0 19±2 291±14 92±5 17±2
0.05 46±27 334±18* 462±56* 16±6
0.1 44±4* 1286±30* 206±145 20±8
0.25 20±3 1103±5* 128±46 22±3
0.5 13±6 545±7* 68±6ǂ 13±3
1 7±2ǂ 150±14ǂ 59±3ǂ 21±2
2.5 8±2ǂ 150±5ǂ 64±16 22±4
5 8±2ǂ 29±7ǂ 35±16ǂ 61±2
48 h Interferon gamma secreted in pg/mL (mean±S.D.)
[PCP] μM F197 F211 F214 F238
0 27±2 282±43 253±8 94±13
0.05 50±18 1089±52* 497±22* 100±2
0.1 37±4* 1011±28* 355±52 101±1
0.25 33±5 499±88* 238±122 100±1
0.5 20±1ǂ 730±11* 263±140 67±8ǂ
1 12±4ǂ 776±18* 208±22 71±2
2.5 15±5ǂ 362±43 68±5ǂ 63±4ǂ
5 5±1ǂ 12±6ǂ 16±11ǂ 86±3
6day Interferon gamma secreted in pg/mL (mean±S.D.)
[PCP] μM F197 F211 F214 F238
0 43±13 240±6 70±3 65±2
0.05 218±165 632±9* 144±2* 79±2*
0.1 192±66 262±11 57±25 76±5
0.25 107±8* 321±9* 63±11 103±3*
0.5 4±7ǂ 468±22* 62±8 84±3*
1 26±9 170±8ǂ 80±24 82±6*
2.5 55±11 120±16ǂ 58±15 47±3ǂ
5 5±9ǂ 44±2ǂ 29±3ǂ 80±2*
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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Table 3B
Effects of 24 h, 48 h, 6 day exposures to PCP on TNFα secretion from PBMCs.
24 h TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM F121 F123 F146 F151
0 722±27 206±6 1303±114 1737±30
0.1 633±60 182±7ǂ 1276±103 764±117ǂ
0.25 659±40 190±5ǂ 1154±49 728±53ǂ
0.5 655±38 188±14 1257±134 948±81ǂ
1 725±20 208±15 1162±75 1210±88ǂ
2.5 728±22 256±12* 1091±54 1235±181ǂ
5 779±13* 426±24* 1488±104 999±81ǂ
48 h TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM F121 F123 F146 F151
0 81±9 37±4 616±13 680±44
0.1 130±23* 49±1* 884±74* 318±41ǂ
0.25 44±15ǂ 41±2 560±34 441±58ǂ
0.5 14±7ǂ 43±1 797±61* 487±52ǂ
1 18±15ǂ 51±2* 780±32* 380±34ǂ
2.5 39±12ǂ 71±6* 1094±32* 499±34ǂ
5 67±4 131±15* 514±57 218±31ǂ
6 day TNF alpha secreted in pg/mL (mean±S.D.)
[PCP] uM F121 F123 F146 F151
0 450±11 88±2 637±87 975±.85
0.05 512±4* 54±2ǂ 322±155 694±59ǂ
0.1 494±16* 68±4ǂ 452±154 777±106
0.25 476±11* 53±2ǂ 346±177 743±178
0.5 462±51 69±1ǂ 509±64 909±57
1 499±12* 62±3ǂ 516±176 924±94
2.5 484±13* 58±5ǂ 314±122ǂ 840±41
5 462±6 46±2ǂ 341±35ǂ 662±121ǂ
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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Table 4A
Effects of 24 h, 48 h, 6 day exposures to DDT on IFNγ secretion from NK cells.
24 h Interferon gamma secreted in pg/mL (mean±S.D.)
[DDT] μM F351 F361 F366 F375
0 6973±107 32±4 195±18 88±6
0.025 10003±140* 26±5 381±16* 66±8ǂ
0.05 11156±201* 30±5 329±5* 83±6
0.1 9713±483* 31±2 354±32* 98±4
0.25 8912±517* 20±3ǂ 167±21 117±9*
0.5 7705±266* 22±0 351±33* 104±3*
1 10675±283* 17±1ǂ 563±61* 133±3*
2.5 1997±60ǂ 32±4 703±99* 101±3*
48 h Interferon gamma secreted in pg/mL (mean±S.D.)
[DDT] μM F351 F361 F366 F375
0 24086±368 24±2 305±15 152±6
0.025 19420±1140ǂ 175±30* 501±18* 130±26
0.05 19172±1402ǂ 50±40 615±6* 84±8ǂ
0.1 26496±1038* 26±24 443±47* 221±20*
0.25 27048±1321 10±4ǂ 300±11 116±4ǂ
0.5 30763±1029* 6±1ǂ 1163±198* 98±2ǂ
1 18963±15299 3±1ǂ 234±14ǂ 142±7
2.5 20439±243ǂ 5±1ǂ 338±23 132±11
6day Interferon gamma secreted in pg/mL (mean±S.D.)
[DDT] μM F351 F361 F366 F375
0 14108±782 13±6 852±59 66±4
0.025 23330±1034* 163±28* 592±10ǂ 146±120
0.05 25531±261* 46±37 616±17ǂ 66±10
0.1 13142±189 24±22 563±40ǂ 91±15
0.25 19323±737* 9±4 414±37ǂ 66±3
0.5 13038±695 6±1 677±6ǂ 69±3
1 21802±762* 3±1 344±25ǂ 55±1ǂ
2.5 6705±1144ǂ 4±0 836±106 56±6
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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Table 4B
Effects of 24 h, 48 h, 6 day exposures to DDT on TNFα secretion from NK cells.
24 h TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] M KB171 KB178 KB185 KB190
0 33±1 50±18 0±1 6±8
0.025 36±2 0±43 0±2 4±22
0.05 36±2 36±39 0±2 41±17
0.1 35±1 0±7ǂ 0±3 46±41
0.25 67±54 74±36 0±1 15±1
0.5 38±2 39±49 1±3 18±10
1 72±55 0±19ǂ* 0±3 26±16
2.5 35±2 53±54 7±4* 7±1
48 h TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] μM KB171 KB178 KB185 KB190
0 4±2 221±7 6±2 17±6
0.025 7±3 277±43 8±1 11±5
0.05 5±2 322±24* 7±1 7±5
0.1 7±1 295±20* 8±1 8±4
0.25 7±3 346±31* 9±1 28±12
0.5 7±1 306±25* 9±1 14±2
1 6±2 451±42* 8±1 20±16
2.5 6±1 342±63 8±1 13±2
6 day TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] μM KB171 KB178 KB185 KB190
0 0±1 3±7 2±1 1±1
0.025 0±1 2±3 1±1 1±1
0.05 0±2 1±1 2±1 0±2
0.1 0±3 6±2 2±2 1±1
0.25 0±1 1±3 1±1 2±1
0.5 0±1 9±7 1±1 0±5
1 0±1 3±2 7±6 3±2
2.5 0±1 5±5 2±1 2±1
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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Table 5B
Effects of 24 h, 48 h, 6 day exposures to DDT on TNFα secretion from MD-PBMCs.
24 h TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] uM F106 F174 F178 F180
0 3273±498 631±35 1605±112 712±20
0.025 1478±301ǂ 461±61ǂ 931±141ǂ 444±73ǂ
0.05 2083±1051 455±17ǂ 1544±48 400±9ǂ
0.1 2704±102 452±19ǂ 1403±86 392±28ǂ
0.25 2837±585 406±4ǂ 1492±64 402±39ǂ
0.5 4042±216 454±38ǂ 1518±111 409±43ǂ
1 3724±242 525±88 1352±119 476±82
2.5 5375±200* 570±31 2142±9* 1015±45*
48 h TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] uM F106 F174 F178 F180
0 869±49 778±22 526±57 0±35
0.025 627±24ǂ 454±0ǂ 250±54ǂ 0±14
0.05 808±40 497±0ǂ 278±53ǂ 0±35
0.1 568±35ǂ 530±22ǂ 300±22ǂ 0±52
0.25 659±26ǂ 702±16ǂ 378±34ǂ 0±36
0.5 731±23ǂ 683±14ǂ 454±45 0±15
1 712±42ǂ 688±58 573±107 0±35
2.5 1205±12* 1388±64* 740±66* 0±10
6day TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] uM F106 F174 F178 F180
0 140±65 784±41 659±35 171±19
0.025 57±61ǂ 317±37ǂ 12±48ǂ 218±191
0.05 319±76 429±22ǂ 214±143ǂ 101±10ǂ
0.1 124±93 381±54ǂ 132±31ǂ 94±4ǂ
0.25 243±58 431±12ǂ 196±56ǂ 126±29
0.5 321±96 465±98ǂ 148±4ǂ 654±39*
1 186±96 555±186 176±74ǂ 88±11ǂ
2.5 445±36* 641±8ǂ 379±18ǂ 197±5
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
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ND=Not Determined
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Table 6B
Effects of 24 h, 48 h, 6 day exposures to DDT on TNFα secretion from PBMCs.
24 h TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] uM F110 F111 F112 F164
0 441±29 2837±95 2077±76 8±10
0.025 429±109 2859±107 1941±39 62±28
0.05 460±100 2820±123 1860±77ǂ 83±7*
0.1 380±5 3080±94* 1843±52ǂ 92±22*
0.25 431±15 3237±29* 2057±62 211±12*
0.5 410±36 3037±91 1897±37ǂ 177±32*
1 428±17 3093±46* 2007±58 362±23*
2.5 591±34* 3219±98* 2195±24 581±65*
48 h TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] uM F110 F111 F112 F164
0 74±2 1945±166 671±16 51±4
0.025 77±1 2087±190 681±91 178±42*
0.05 77±5 2054±354 638±5 157±37*
0.1 67±1ǂ 2012±272 636±18 120±19*
0.25 79±7 2326±4 684±20 142±13*
0.5 92±7* 2412±75* 632±10ǂ 166±15*
1 100±4* 1982±306 694±22 163±22*
2.5 134±8* 2140±67 638±169 282±9*
6 day TNF alpha secreted in pg/mL (mean±S.D.)
[DDT] uM F110 F111 F112 F164
0 9±1 1905±571 27±9 82±1
0.025 9±1 14063±650 19±8 330±266
0.05 5±1ǂ 14682±35 23±2 144±74
0.1 7±1 1375±126 23±3 234±125
0.25 9±1 1510±64 22±1 124±24
0.5 9±1 1489±22 27±2 234±122
1 9±2 1485±74 25±3 173±57
2.5 13±2 1770±60 28±9 369±67*
Values are mean±S.D. of triplicate determinations.
*
Indicates a significant increase
ǂ
indicates a significant decrease in secretion compared to control cells (cells treated with vehicle alone), p<0.05
ND=Not Determined
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